{"id":"W2950962041","doi":"10.1136/annrheumdis-2019-eular.643","title":"AB0753 COMPARING COMPOSITE MEASURES OF DISEASE ACTIVITY IN PSORIATIC ARTHRITIS: RESULTS FROM A RANDOMIZED PHASE 2 TRIAL WITH GUSELKUMAB","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Krembil Foundation; University of Toronto","funders":"Celgene; Pfizer; British Society for Rheumatology; Eli Lilly and Company","keywords":"Medicine; Psoriatic arthritis; Ustekinumab; Internal medicine; Psoriasis; Psoriasis Area and Severity Index; Placebo; Arthritis; Gastroenterology; Disease; Immunology; Adalimumab; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00345055,0.002320517,0.004711368,0.0006977076,0.0004826594,0.001533227,0.001155304,0.002158833,0.007022179],"category_scores_gemma":[0.002383066,0.001025698,0.004127858,0.0007142359,0.001645826,0.001600993,0.0006177117,0.00432749,0.001347117],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009116443,"about_ca_system_score_gemma":0.00121059,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009835463,"about_ca_topic_score_gemma":0.001751109,"domain_scores_codex":[0.9978442,0.001362227,0.0001287271,0.0002453925,0.0001353011,0.0002842563],"domain_scores_gemma":[0.9985194,0.0005924177,0.000325128,0.0001375886,0.00007247296,0.0003530311],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9775464,0.003630205,0.0005144441,0.0003840553,0.001644424,0.0000262669,0.00002591717,0.0002789821,0.002021471,0.00006634562,0.0003824256,0.0134791],"study_design_scores_gemma":[0.9519639,0.04477664,0.001666701,0.0000241392,0.0007806601,0.0000213968,0.00001376456,0.0002710607,0.0002173046,0.00007513149,0.0001775645,0.00001167681],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9865817,0.007706305,0.0007030586,0.0006919132,0.0005448678,0.001226812,0.0007941604,0.0001423413,0.001608846],"genre_scores_gemma":[0.989338,0.003276634,0.001349764,0.001118365,0.0005730538,0.002009598,0.001015402,0.00003716625,0.001281948],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007022179,"threshold_uncertainty_score":0.0234915,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0517268126852062,"score_gpt":0.3159046894758771,"score_spread":0.264177876790671,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}